374 related articles for article (PubMed ID: 33672181)
1. Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means.
Carse S; Bergant M; Schäfer G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672181
[TBL] [Abstract][Full Text] [Related]
2. Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.
Farmer E; Cheng MA; Hung CF; Wu TC
Recent Results Cancer Res; 2021; 217():157-195. PubMed ID: 33200366
[TBL] [Abstract][Full Text] [Related]
3. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.
Asiaf A; Ahmad ST; Mohammad SO; Zargar MA
Eur J Cancer Prev; 2014 May; 23(3):206-24. PubMed ID: 24129107
[TBL] [Abstract][Full Text] [Related]
4. Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection.
Carse S; Lang D; Katz AA; Schäfer G
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960740
[TBL] [Abstract][Full Text] [Related]
5. An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy.
Yousefi Z; Aria H; Ghaedrahmati F; Bakhtiari T; Azizi M; Bastan R; Hosseini R; Eskandari N
Front Immunol; 2021; 12():805695. PubMed ID: 35154080
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and cervical cancer.
Okunade KS
J Obstet Gynaecol; 2020 Jul; 40(5):602-608. PubMed ID: 31500479
[TBL] [Abstract][Full Text] [Related]
7. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
[TBL] [Abstract][Full Text] [Related]
8. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
9. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and vaccination in cervical cancer.
Wang KL
Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccines for cervical cancer.
Murakami M; Gurski KJ; Steller MA
J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies.
Tota JE; Chevarie-Davis M; Richardson LA; Devries M; Franco EL
Prev Med; 2011 Oct; 53 Suppl 1():S12-21. PubMed ID: 21962466
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.
McCormack PL
Drugs; 2014 Jul; 74(11):1253-83. PubMed ID: 25022951
[TBL] [Abstract][Full Text] [Related]
14. Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles.
Yang F; Mariz FC; Zhao X; Spagnoli G; Ottonello S; Müller M
Front Immunol; 2020; 11():606569. PubMed ID: 33343580
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
16. Surfactant Protein A Impairs Genital HPV16 Pseudovirus Infection by Innate Immune Cell Activation in A Murine Model.
Ujma S; Carse S; Chetty A; Horsnell W; Clark H; Madsen J; Mackay RM; Watson A; Griffiths M; Katz AA; Schäfer G
Pathogens; 2019 Dec; 8(4):. PubMed ID: 31817644
[No Abstract] [Full Text] [Related]
17. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
18. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
19. 'Secondary prevention' against female HPV infection: literature review of the role of carrageenan.
Calagna G; Maranto M; Paola C; Capra G; Perino A; Chiantera V; Cucinella G
Expert Rev Anti Infect Ther; 2020 Sep; 18(9):865-874. PubMed ID: 32552158
[No Abstract] [Full Text] [Related]
20. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
